Glympse Bio

Glympse Bio

Glympse Bio

Transforming disease monitoring for patients, providers, and society. Imagine a future where a simple urine test can detect deadly diseases before they get out of control. A future when diseases can be intercepted and people dont become patients.
Raised
$22M
Follow us
Alexa global traffic share
Twitter followers
09 Oct 2018
$22,000,000
Venture capital (Series A)

Glympse Bio Raises $22m Series A Financing

FinSMEs
+1